Role of heparan sulfate proteoglycans in the binding and uptake of apolipoprotein E-enriched remnant lipoproteins by cultured cells

J Biol Chem. 1993 May 15;268(14):10160-7.


Addition of apolipoprotein (apo) E to rabbit beta-very low density lipoproteins (beta-VLDL) has been shown to result in a marked enhancement of their binding and uptake by various cell types. Apolipoprotein E binds to lipoprotein receptors and proteoglycans. To distinguish between apoE binding to these sites, cells were treated with heparinase. Heparinase treatment of receptor-negative familial hypercholesterolemic (FH) fibroblasts and human hepatoma cells (HepG2) released 30-40% of newly synthesized cell surface 35S-labeled proteoglycans and decreased the binding of beta-VLDL+apoE to FH and normal fibroblasts and HepG2 cells by more than 80%. Furthermore, heparinase treatment significantly decreased the uptake of fluorescently labeled beta-VLDL+apoE by HepG2 cells and decreased cholesteryl ester synthesis in FH fibroblasts by 75%. Likewise, canine chylomicron remnants enriched in apoE demonstrated enhanced binding that was 80% inhibited by heparinase treatment of HepG2 cells. Heparinase treatment did not affect beta-VLDL (without added apoE) or low density lipoprotein (LDL) binding to these cells or the binding activity of beta-VLDL+apoE to the LDL receptor-related protein (LRP) or to the LDL receptor on ligand blots. Chinese hamster ovary (CHO) mutant cells lacking the synthesis of either heparan sulfate (pgsD-677) or all proteoglycans (pgsA-745) did not display any enhanced binding of the beta-VLDL+apoE. By comparison, wild-type CHO cells demonstrated enhanced binding of beta-VLDL+apoE that could be abolished by treatment with heparinase. These mutant cells and wild-type CHO cells possessed a similar amount of LRP, as determined by ligand blot analyses and by alpha 2-macroglobulin binding, and possessed a similar amount of LDL receptor activity, as determined by LDL binding. Therefore, we would interpret these data as showing that heparan sulfate proteoglycan may be involved in the initial binding of the apoE-enriched remnants with the subsequent involvement of the LRP in the uptake of these lipoproteins. It remains to be determined whether the heparan sulfate proteoglycan can function by itself in both the binding and internalization of the apoE-enriched remnants or whether the proteoglycan is part of a complex with LRP that mediates a two-step process, i.e. binding and subsequent internalization by the receptor.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Apolipoproteins E / metabolism*
  • Biological Transport
  • CHO Cells
  • Carcinoma, Hepatocellular
  • Cell Membrane / metabolism
  • Cells, Cultured
  • Cholesterol / metabolism
  • Cholesterol Esters / metabolism
  • Cricetinae
  • Diet, Atherogenic
  • Fibroblasts / metabolism
  • Heparan Sulfate Proteoglycans
  • Heparin Lyase
  • Heparitin Sulfate / genetics
  • Heparitin Sulfate / metabolism*
  • Humans
  • Hyperlipoproteinemia Type II / metabolism*
  • Lipoproteins, LDL / metabolism
  • Lipoproteins, VLDL / blood
  • Lipoproteins, VLDL / isolation & purification
  • Lipoproteins, VLDL / metabolism
  • Liver / metabolism*
  • Liver Neoplasms
  • Membrane Proteins / isolation & purification
  • Membrane Proteins / metabolism
  • Polysaccharide-Lyases / pharmacology
  • Protein Binding
  • Proteoglycans / genetics
  • Proteoglycans / metabolism*
  • Rabbits
  • Rats
  • Receptors, LDL / metabolism
  • Transfection
  • Tumor Cells, Cultured
  • alpha-Macroglobulins / metabolism


  • Apolipoproteins E
  • Cholesterol Esters
  • Heparan Sulfate Proteoglycans
  • Lipoproteins, LDL
  • Lipoproteins, VLDL
  • Membrane Proteins
  • Proteoglycans
  • Receptors, LDL
  • alpha-Macroglobulins
  • Heparitin Sulfate
  • Cholesterol
  • Polysaccharide-Lyases
  • Heparin Lyase